BIO-key(R) International, Inc. Partners Highlight Fingerprint Biometric
Technology Solutions for Healthcare at HIMSS
Multiple Partners Presenting BIO-key's Fingerprint Biometric
Authentication Solution for EHR & EPCS
WALL, NJ -- (Marketwire) -- 03/04/13 -- BIO-key International, Inc.
(OTCQB: BKYI), a global leader in fingerprint biometric
identification solutions, advanced mobile credentialing and identity
verification technologies, today reported that the company will be
attending the Health Information and Management Systems Society
(HIMSS) annual meeting in New Orleans, Louisiana, March 3rd - 7th
supporting our partners as they present BIO-key technology to
attendees at the HIMSS conference.
BIO-key will have a strong presence at HIMSS 2013, as healthcare
partners such as Allscripts, Epic, IBM, CA Technologies, Caradigm,
Indigo Identyware and Healthcast attending the event offer BIO-key
Company partners will be offering demonstrations of integrated
solutions for secure, compliant two-factor authentication. BIO-key
customer McKesson will also be in attendance at HIMSS. Our
fingerprint biometric technology is embedded within their
AcuDoseRx(R) automated medication dispensing cabinets.
BIO-key's fingerprint biometric technology offers strong
authentication in addition to optimum convenience enabling healthcare
providers to greatly reduce or eliminate the use of passwords, cards
and tokens and increase the amount of time caring for patients. The
company's software achieved top scores for speed and accuracy in the
most recent National Institute for Standards of Technology (NIST)
biometric evaluation. NIST sets the standards for the DEA
ePrescription compliance guidelines.
"The HIMSS conference allows BIO-key and our healthcare partners to
co-present innovative solutions for EHR systems to the CEO's and
CIO's from leading hospitals and clinics," stated Mike DePasquale,
CEO, BIO-key. "The provider's frustration with passwords along with
the organizations requirement to meet strict ePrescription compliance
guidelines is motivating healthcare executives to educate themselves
about the benefits of integrating BIO-key technology."
BIO-key International, Inc., headquartered in Wall,
New Jersey, develops and delivers advanced identification solutions
to commercial and government enterprises, integrators, and custom
application developers. BIO-key's award winning, high performance,
scalable, cost-effective and easy-to-deploy biometric finger
identification technology accurately identifies and authenticates
users of wireless and enterprise applications. Our solutions are used
in local embedded OEM products as well as some of the world's largest
identification deployments to improve security, guarantee identity,
and help reduce identity theft. BIO-key's technology is offered
directly or by market leading partners around the world.
BIO-key Safe Harbor Statement
Certain statements contained in this
press release may be construed as "forward-looking statements" as
defined in the Private Securities Litigation Reform Act of 1995 (the
"Act"). The words "estimate," "project," "intends," "expects,"
"anticipates," "believes" and similar expressions are intended to
identify forward-looking statements. Such forward-looking statements
are made based on management's beliefs, as well as assumptions made
by, and information currently available to, management pursuant to
the "safe-harbor" provisions of the Act. These statements are subject
to certain risks and uncertainties that may cause actual results to
differ materially from those projected on the basis of these
statements. These risks and uncertainties include, without
limitation, our history of losses and limited revenue, our ability to
develop new products and evolve existing ones, the impact on our
business of the recent financial crisis in the global capital markets
and negative global economic trends, our ability to attract and
retain key personnel. For a more complete description of these and
other risk factors that may affect the future performance of BIO-key
International, Inc., see "Risk Factors" in the Company's Annual
Report on Form 10-K for the year ended December 31, 2011 and its
other filings with the Securities and Exchange Commission. Readers
are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date made. The Company also
undertakes no obligation to disclose any revision to these
forward-looking statements to reflect events or circumstances after
the date made or to reflect the occurrence of unanticipated events.
BIO-key International, Inc.
Press spacebar to pause and continue. Press esc to stop.